Brian Feldman MD, MPH

Education

2008, Master of Public Health, Epidemiology, Lineberger Clinical Fellow, Cancer Control and Prevention, University of North Carolina, Chapel Hill
2008, Pediatric Hematology-Oncology Clinical Fellowship, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
2004, Pediatric Residency, Naval Medical Center Portsmouth, Virginia
2001, Pediatric Internship, Naval Medical Portsmouth, Virginia
2001, Doctor of Medicine, Eastern Virginia Medical School, Norfolk, Virginia
1997, Bachelor of Science, Biomedical Engineering, Duke University, Durham, North Carolina
1997, Bachelor of Science, Electrical and Computer Engineering, Duke University, Durham, North Carolina

Biography

Captain Feldman was born in San Diego, California the son of a Naval Flight Officer. A graduate of Duke University with a dual degree in biomedical and electrical and computer engineering in 1997, he was accepted to the Health Professions Scholarship Program and graduated from Eastern Virginia Medical School in Norfolk Virginia in 2001.

After completing residency at the Naval Medical Center, Portsmouth he served as a staff Pediatrician at the Halyburton Naval Hospital at Marine Corps Air Station, Cherry Point. He was selected for specialty training in Pediatric Hematology-Oncology at the University of North Carolina at Chapel Hill. He completed a 2 year cancer prevention fellowship and earned a Master of Public Health in Epidemiology with research on the associations between perinatal vitamins and cancer.

He returned to the Naval Medical Center, Portsmouth Virginia and served in numerous positions throughout the hospital including the Director of Pediatric Specialty Services, Inpatient Medical Director, Associate Director of Medical Services, and Chairman of the Pediatric Department while maintaining full time clinical practice. He established the first clinical directorate of the Tidewater Multi-Service Market Pediatric Service Line, partnering with the Air Force and Army to expand inpatient services in the tidewater region.

Experienced in humanitarian assistance and disaster response, Captain Feldman deployed with the USNS COMFORT (T-AH 20) as the Pediatric Department Head in support of Continuing Promise 2011 and subsequently served as the Director of Medical Services from 2011-2015, including extensive mission development for Continuing Promise 2013 and 2015.

From 2008-2014, he led the Uniformed Services Oncology Consortium to ensure access to over 50 active clinical research treatment protocols for children and active duty patients with cancer to ensure that military dependents received cutting edge therapy. He served as the government sponsor for the Health Outcomes Center of Excellence from 2013-2019 leveraging DoD data to help military investigators address drug safety, epidemiology, and health disparities.

Feldman led numerous Defense Support to Civilian Authority health services missions, and a deployment as the Task Force Surgeon for the IWO JIMA (LHD-7) Amphibious Ready Group in 2017-2018. As Executive Officer of the Naval Submarine Medical Research Laboratory from July 2019–July 2021, he managed the comprehensive day-to-day operations of the Navy’s only laboratory focused on research solutions to aid warfighters aboard the most medically challenging undersea platforms and mission sets in the US Navy.

From July 2021-April 2023, he served as the Commander of the Navy and Marine Corps Public Health Center, and inaugural Director of the Defense Centers for Public Health, Portsmouth VA, supporting the global operational Public Health Policy and Management in support of BUMED and the Defense Health Agency to include 10 echelon 5 tenant commands involving the management of Radiation Health Protection Missions, Blood Borne Infection Management, Entomology, Environmental Preventive Medicine, Navy Drug Screening, Industrial Hygiene Laboratories, Environmental Programs, Epidemiological and Health Analysis, Health promotion and wellness policy, programs and execution for the fleet. He currently serves as the Commander of Navy Medicine Readiness and Training Command Portsmouth and the Director of Naval Medical Center Portsmouth.

Career Highlights: Positions, Projects, Deployements, Awards and Additional Publications

Director of Medical Services, USNS Comfort (T-AH 20) 2011-2014

Amphibious Task Force Surgeon, USS IWO JIMA (LHD 7) Amphibious Readiness Group 2018 5th and 6th Fleet AOR

Expeditionary Strike Group Surgeon, Defense Support of Civilian Authorities 2017 NORTHCOM/SOUTHCOM AOR

Co-Principal Investigator, Uniformed Services Oncology Consortium 2008-2013 • Lead institution for DoD’s Children's Oncology Group Research Program ensuring access to upwards of 150 studies of leukemia, brain tumors and other principal tumors of childhood. 54 active protocols enabled gold standard cancer care for children and adults equivalent to $11.3 million annually for deferral of comprehensive civilian care. Implemented enterprise-wide centralized institutional review and protocol sharing to reduce

Commander, Navy and Marine Corps Public Health Center, Portsmouth VA July 2021-2023

Executive Officer, Naval Submarine Medical Research Laboratory, Groton CT June 2019-June 2021

Representative Bibliography

Feldman, B L, Zanetti, R A. Sicignano, N. Warwick, A. Late Effect Screening of Acute Lymphoblastic Leukemia Survivors in the Military Healthcare System. Accepted by Pediatrics Aug 2021.

Zanetti, R, Feldman, B, Porea T. “Index of Suspicion: Microcytic Anemia”, Pediatr Rev. 2021 Jan;42(1):41-43.

Gary Schneider, ScD, Tobias Banaschewski, MD, PhD, CAPT Brian L Feldman, M.D. MPH, Per A Gustafsson, MD, PhD, Brian Murphy, MS, Matthew Reynolds, PhD, David R Coghill, MD, and William M Spalding, MS. Weight and Height in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Longitudinal Database Study Assessing the Impact of Guanfacine, Stimulants, and No Pharmacotherapy. J Child Adolesc Psychopharmacol. 2019 May 1; 29(4): 285–304.

“Validity Evidence for a Serious Game to Assess Performance on Critical Pediatric Emergency Medicine Scenarios.” James M. Gerard; Anthony J. Scalzo; Matthew A. Borgman; Christopher M. Watson; Chelsie E. Byrnes; Todd P. Chang; Marc Auerbach; David O. Kessler; Brian L. Feldman; Brian S. Payne; Sohail Nibras; Riti K. Chokshi; Joseph O. Lopreiato. in Healthcare: The Journal of the Society For Simulation in Healthcare. 13(3):168–180, JUN 2018.

Sun, J., Hakobyan, N., Valentino, L. A., Feldman, B. L., Samulski, R. J. & Monahan, P. E.” Gene Therapy for Hemophilia: Progress to Date.” Chapin, J. C. & Monahan, P. E. Feb 1 2018 In : BioDrugsDec 1 2008 In : Blood.

Biswas AK, Feldman BL, Davis DH, Zintz EA. Myocardial ischemia as a result of severe benzodiazepine and opioid withdrawal. Clin Toxicol (Phila). 2005;43(3):207-9.

Feldman, B.L, Shope, T.R. Cost Comparison of Current Methods of Newborn Screening vs. Expanded Newborn Metabolic Screening with Tandem Mass Spectrometry

Ralston ME, Wilde W, Kelty L, Ham C, Ryan S, Feldman B. Oral midazolam anxiolysis for facial laceration repair in children: A randomized controlled trial